Prognosis
EU in ‘Damage Control’ as Bloc Turns to Vaccine Export Curbs
- AstraZeneca alleged to have reneged on EU supply agreements
- Anglo-Swedish vaccine maker supplies doses to both EU and U.K.
This article is for subscribers only.
The European Union’s drastic plan to restrict exports of Covid-19 shots is more of a political ploy as prospects of successfully suing AstraZeneca Plc for reining in supplies of its vaccine appear slim, lawyers and trade experts said.
The bloc’s executive arm announced on Friday that vaccine makers including AstraZeneca must obtain prior authorization before sending shots manufactured in the bloc to other countries. The escalation follows a very public dispute with the company triggered by production delays at a Belgian plant.